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Malnutrition and Variability
in CD4+ Cell Counts
in African Populations
To the Editor—Williams et al. [1] inves-
tigated a mathematical model to predict
the distribution of CD4+ cell counts
among HIV-positive adults by use of the
distribution among HIV-negative adults
in African populations. The study was
mainly based on data collected in South
Africa and Zambia. The authors noted
that CD4+ cell counts vary widely within
and among populations. The CD4+ cell
count distributions among HIV-negative
people had a higher mean in South Africa
than in Zambia, but the mean rate of de-
crease in CD4+ cell count among HIV-
positive people was higher in South Africa,
and mean survival was shorter in South
Africa than in Zambia at a given CD4+ cell
count. The authors did not provide an
explanation for these observations, which
are important for the prediction of mor-
tality at a given CD4+ cell count. Predic-
tions of disease progression and mortality
inform the decision-making process about
the commencement of antiretroviral treat-
ment in an individual HIV-infected patient.
The authors’ findings could be ex-
plained by the impact of nutritional status
on CD4+ cell counts. In malnutrition, the
thymus gland undergoes severe atrophy
due to apoptosis-induced thymocyte de-
pletion, particularly affecting the imma-
ture CD4+ cells, as well as a decrease in
cell proliferation [2]. This process has
been linked to decreased leptin and in-
creased glucocorticoid levels in malnutri-
tion [3]. CD4+ cell counts were found to
be lower in children with nonedematous
malnutrition than in those with edema-
tous malnutrition [4]. The population in
Zambia at the time the studies the authors
referred to were conducted had a signifi-
cantly higher proportion of malnourished
people than did the population in South
Africa, where the economic conditions
started to improve with increased rates of
obesity [5, 6]. This may explain the lower
mean CD4+ cell count among HIV-neg-
ative people in the Zambian study. It is
unlikely that the lower mean CD4+ cell
count in Zambia was due to an increased
burden of other infectious diseases, be-
cause increased cytokine levels due to on-
going infections would (for example via
tumor necrosis factor and NF-kB–medi-
ated long terminal repeat–drivenincreased
HIV transcription) have led to accelerated
disease progression and increased mortal-
ity due to HIV infection. Malnutrition
rather than increased infectious-disease
burden is, therefore, also the most likely
explanation for the finding of a study in
Ethiopia in which, at lower CD4+ cell
counts, life expectancy in HIV-positive pa-
tients was similar to that in The Nether-
lands [6]. Low CD4+ cell counts due to
malnutrition are associated with a more
functional immune system than are low
CD4+ cell counts due to HIV-induced T
cell apoptosis, and many immune func-
tions are well preserved in people with
malnutrition [7]. Future mathematical
models predicting disease progression and
mortality in HIV-positive populations
need to relate CD4+ cell counts to body
mass index.
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Reply to Eisenhut
To the Editor—Eisenhut [1] discusses the
role of malnutrition as a determinant of
CD4+ cell counts, especially in Africa. It is
known that genetic, immunological, phys-
iological, and behavioral factors are as-
sociated with CD4+ cell counts within and
among populations, and we referred to
some of these factors in our article [2].
However, our intention was not to explain
the reasons for this variation but, rather,
to investigate the more limited question
of the relationship between the distribu-
tions of CD4+ cell counts among HIV-
positive and HIV-negative people from the
same population. The surprising conclu-
sion was that, in populations in which the
initial mean CD4+ cell count is low, the
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rate of decline in CD4+ cell counts is cor-
respondingly low, so that the time to AIDS
and death is not substantially affected.
Eisenhut suggests that CD4+ cell counts
were lower in the Zambian population
than in the South African population be-
cause the Zambians were malnourished,
and he suggests that malnutrition may not
result in a significant deterioration in im-
mune function, even if it leads to a re-
duction in CD4+ cell counts. He suggests
that, taken together, these factors may ex-
plain the similar time to death in the 2
populations. To this interesting sugges-
tion, we must reply “perhaps.”
First, without comparative measure-
ments of nutritional status, it is not certain
that the Zambians were less well nourished
than the South Africans. Nutritional status
was, however, measured in the Zambian
study, and people with opportunistic in-
fections, but not asymptomatic HIV in-
fection, showed signs of malnourishment
[3]; however, malnutrition could have
been the cause or the effect of the op-
portunistic infections [4]. Second, there is
uncertainty about the role of malnutrition
in lowering CD4+ cell counts [5] and lead-
ing to functional impairment of the im-
mune system [5, 6].
If the nutritional statuses of the 2 pop-
ulations were indeed different, and if mal-
nutrition reduces CD4+ cell counts but
also leads to a functional deterioration in
the immune system [4], we might have
expected a more rapid progression to
AIDS and death among the Zambians,
compared with that among the South Af-
ricans. This appears not to be the case.
The putative explanation for this is that,
since CD4+ cells are prime targets for HIV,
the lack of CD4+ cells in Zambians as com-
pared with South Africans limits the ability
of the virus to replicate, and this balances
out the effect of malnutrition on disease
progression and, therefore, survival.
We believe that these questions still de-
mand answers, especially in view of the
fact that CD4+ cell counts are widely used
as part of the algorithm for deciding when
to start antiretroviral therapy. Better data
on the determinants of CD4+ cell counts,
together with more extensive data on time
trends in CD4+ cell counts and survival,
might help us to develop better predictive
models of the outcome of HIV infections.
This, in turn, could help to bridge the gap
between what is happening at the cellular
level and what is happening at the pop-
ulation level, with important implications
for the control of HIV/AIDS. The possi-
bilities for doing such work are now lim-
ited, since it is essential that HIV-positive
people have access to antiretroviral ther-
apy. However, sufficient historical data
must have been collected over the past 25
years in the Multi-centre AIDS Cohort
Study (MACS), the Concerted Action on
Sero-Conversion to AIDS and Death in
Europe (CASCADE) Collaboration, and
other such studies to help resolve these
questions.
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